Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ketorolac for Stanford type A aortic dissection surgery
ChiCTR2300074394Phase 2Suspended
- Sponsor
- Nanjing Drum-Tower Hospital
- Start
- Aug 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in aortic dissection comparing Ketorolac arm with Placebo arm (2 arms). Primary endpoints: death, malperfusion and 2 more. Started Aug 2023; status: suspended.
02
Drugs
ketorolac
03
Conditions
aortic dissection
Beyond the preview
Go deeper on ChiCTR2300074394.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300074394.